. "6-aminopurine; Cu(II) complexes; antiradical activity"@en . . "Tr\u00E1vn\u00ED\u010Dek, Zden\u011Bk" . "Popa, Igor" . "P(GA203/04/1168)" . . . "5"^^ . "Cu(II) komplexy s purinov\u00FDmi deriv\u00E1ty, vlastnosti a antiradik\u00E1lov\u00E1 aktivita"@cs . "RIV/62157124:16370/06:00000764" . "Deriv\u00E1ty 6-benzylaminopurinu jsou zn\u00E1m\u00E9 \u0159adou sv\u00FDch biologick\u00FDch \u00FA\u010Dink\u016F. V rostlinn\u00FDch tk\u00E1n\u00EDch, kde se p\u0159irozen\u011B vyskytuj\u00ED jako fytohormony stimuluj\u00EDc\u00ED r\u016Fst a d\u011Blen\u00ED bun\u011Bk1. Na druhou stranu mohou vyvolat zastaven\u00ED r\u016Fstu bun\u011Bk \u017Eivo\u010Di \u0161n\u00FDch tumor\u016F. Kancerostatick\u00FD \u00FA\u010Dinek m\u016F\u017Ee b\u00FDt umocn\u011Bn tvorbou komplexu s vhodn\u00FDm p\u0159echodn\u00FDm kovem (Pt, Pd, Co, Fe, Cu)2,3. Reakc\u00ED Cu(ClO4)2 * 6 H2O s deriv\u00E1ty 6-benzylaminopurinu byly p\u0159ipraveny dvojjadern\u00E9 komplexy o slo\u017Een\u00ED [Cu2(\u00B5-L1−8)4 (ClO4)2](ClO4)2*n solv, kde L1−8 = r\u016Fzn\u011B substituovan \u00E9 deriv\u00E1ty adeninu, n = 0−4, solv = EtOH, MeOH nebo H2O. Komplexy byly charakterizov\u00E1ny pomoc\u00ED chemick\u00E9 anal\u00FDzy prvk\u016F, IR, UV-Vis, 1H a 13C NMR spektroskopie, magnetochemick\u00FDch a vodivostn\u00EDch m\u011B\u0159en\u00ED. Struktura komplexu [Cu2(\u00B5-L6)4(ClO4)2] (ClO4)2 * 4 EtOH * H2O (obr. 1) byla vy\u0159e\u0161ena pomoc\u00ED monokrystalov\u00E9 rentgenostrukturn\u00ED anal\u00FDzy. Koordina\u010Dn\u00ED sf\u00E9ra centr\u00E1ln\u00EDch atom\u016F p\u0159ipraven\u00FDch dvojjadern \u00FDch Cu(II) komplex\u016F se podob\u00E1 aktivn\u00EDmu m\u00EDstu"@cs . "250"^^ . "Cu(II) complexes with purine derivatives, their properties and antiradical activity"@en . . "16370" . . "Deriv\u00E1ty 6-benzylaminopurinu jsou zn\u00E1m\u00E9 \u0159adou sv\u00FDch biologick\u00FDch \u00FA\u010Dink\u016F. V rostlinn\u00FDch tk\u00E1n\u00EDch, kde se p\u0159irozen\u011B vyskytuj\u00ED jako fytohormony stimuluj\u00EDc\u00ED r\u016Fst a d\u011Blen\u00ED bun\u011Bk1. Na druhou stranu mohou vyvolat zastaven\u00ED r\u016Fstu bun\u011Bk \u017Eivo\u010Di \u0161n\u00FDch tumor\u016F. Kancerostatick\u00FD \u00FA\u010Dinek m\u016F\u017Ee b\u00FDt umocn\u011Bn tvorbou komplexu s vhodn\u00FDm p\u0159echodn\u00FDm kovem (Pt, Pd, Co, Fe, Cu)2,3. Reakc\u00ED Cu(ClO4)2 * 6 H2O s deriv\u00E1ty 6-benzylaminopurinu byly p\u0159ipraveny dvojjadern\u00E9 komplexy o slo\u017Een\u00ED [Cu2(\u00B5-L1−8)4 (ClO4)2](ClO4)2*n solv, kde L1−8 = r\u016Fzn\u011B substituovan \u00E9 deriv\u00E1ty adeninu, n = 0−4, solv = EtOH, MeOH nebo H2O. Komplexy byly charakterizov\u00E1ny pomoc\u00ED chemick\u00E9 anal\u00FDzy prvk\u016F, IR, UV-Vis, 1H a 13C NMR spektroskopie, magnetochemick\u00FDch a vodivostn\u00EDch m\u011B\u0159en\u00ED. Struktura komplexu [Cu2(\u00B5-L6)4(ClO4)2] (ClO4)2 * 4 EtOH * H2O (obr. 1) byla vy\u0159e\u0161ena pomoc\u00ED monokrystalov\u00E9 rentgenostrukturn\u00ED anal\u00FDzy. Koordina\u010Dn\u00ED sf\u00E9ra centr\u00E1ln\u00EDch atom\u016F p\u0159ipraven\u00FDch dvojjadern \u00FDch Cu(II) komplex\u016F se podob\u00E1 aktivn\u00EDmu m\u00EDstu" . . . "Binuclear complexes Cu(II) with 6-aminopurine derivates were prepared and characterized by conventional spectral methods. They showed strong antiradical activity."@en . "Cu(II) komplexy s purinov\u00FDmi deriv\u00E1ty, vlastnosti a antiradik\u00E1lov\u00E1 aktivita"@cs . "1"^^ . "2006-09-07+02:00"^^ . "470135" . "\u00DAst\u00ED nad Labem" . "\u0160indel\u00E1\u0159, Zden\u011Bk" . . . . "2006-09-04+02:00"^^ . . . "RIV/62157124:16370/06:00000764!RIV07-GA0-16370___" . "Cu(II) komplexy s purinov\u00FDmi deriv\u00E1ty, vlastnosti a antiradik\u00E1lov\u00E1 aktivita" . "[C723BD9D6647]" . . "Cu(II) komplexy s purinov\u00FDmi deriv\u00E1ty, vlastnosti a antiradik\u00E1lov\u00E1 aktivita" . "Van\u010Do, J\u00E1n" . . . "Cu(II) complexes with purine derivatives, their properties and antiradical activity"@en . "500"^^ . "Klanicov\u00E1, Alena" . .